Late relapse (>2 years) on surveillance in stage i non-seminomatous germ cell tumours; Predominant seminoma only histology

BJU International

Volumn 106, Issue 11, 2010, Pages 1648-1651

  Nolan, Luke ^a   Wheater, Matthew ^a   Kirby, Julie ^a   Simmonds, Peter ^a   Mead, Graham ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

germ cell cancer; late relapse; seminoma; surveillance

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; ETOPOSIDE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; PRIORITY JOURNAL; SEMINOMA; TERATOMA; TESTIS BIOPSY; TESTIS CANCER; TREATMENT OUTCOME;

ADULT; ALPHA-FETOPROTEINS; ANTINEOPLASTIC AGENTS; BIOPSY; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; TESTICULAR NEOPLASMS; WATCHFUL WAITING;

EID: 78649313698     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09471.x     Document Type: Article

References (19)

1. Toms JR, (ed.). CancerStats Monograph 2004. London: Cancer Research UK, 2004
2. Bhardwa JM, Powles T, Berney D, Baithun S, Nargund VH, Oliver RT,. Assessing the size and stage of testicular germ cell tumours: 1984-2003. BJU Int 2005; 96: 819 - 21
3. De Wit R, Fizazi K,. Controversies in the management of clinical stage I testis cancer. J Clin Oncol 2006; 24: 5482 - 92
4. Francis R, Bower M, Brunström G, et al. Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options. Eur J Cancer 2000; 36: 1925 - 32
5. Read G, Stenning SP, Cullen MH, et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol 1992; 10: 1762 - 8
6. Sogani PC, Perrotti M, Herr HW, Fair WR, Thaler HT, Bosl G,. Clinical stage I testis cancer: long-term outcome of patients on surveillance. J Urol 1998; 159: 855 - 8
7. Peckham MJ, Barrett A, Husband JE, Hendry WF,. Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet 1982; 2: 678 - 80
8. Cullen MH, Stenning SP, Parkinson MC, et al. Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. J Clin Oncol 1996; 14: 1106 - 13
9. Tandstad T, Dahl O, Cohn-Cedermark G, et al. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program. J Clin Oncol 2009; 27: 2122 - 8
10. Foster RS, Donohue JP,. Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma. J Urol 2000; 163: 1788 - 92
11. Albers P, Siener R, Krege S, et al. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. J Clin Oncol 2008; 26: 2966 - 72
12. Thomas R, Dearnaley D, Nicholls J, Norman A, Sampson S, Horwich A,. An analysis of surveillance for stage I combined teratoma - seminoma of the testis. Br J Cancer 1996; 74: 59 - 62
13. Oliver RT, Mason MD, Mead GM, et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 2005; 366: 293 - 300
14. Rustin GJ, Mead GM, Stenning SP, et al. Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197 - the National Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol 2007; 25: 1310 - 5
15. McCrystal MR, Zwi LJ, Harvey VJ,. Late seminomatous relapse of a mixed germ cell tumor of the testis on intensive surveillance. J Urol 1995; 153: 1057 - 9
16. Hinz S, Schrader M, Kempkensteffen C, et al. The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. J Urol 2008; 179: 936 - 40
17. Loehrer PJ Sr, Birch R, Williams SD, Greco FA, Einhorn LH,. Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience. J Clin Oncol 1987; 5: 1212 - 20
18. Motzer R, Bosl G, Heelan R, et al. Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. J Clin Oncol 1987; 5: 1064 - 70
19. Herr HW, Sheinfeld J, Puc HS, et al. Surgery for a post-chemotherapy residual mass in seminoma. J Urol 1997; 157: 860 - 2